Apple Acquires US Biomagnetic Sensing Startup Sonera
Apple has acquired Sonera, a California-based startup specializing in biomagnetic sensing technology that can non-invasively measure neural data without skin contact. The deal was disclosed in a European Commission notice, though financial terms were not revealed. Sonera's technology aims to make brain activity measurement as convenient as tracking heart rate or temperature, with potential applications in prosthetics, disease monitoring, and sports tracking.
A notice published by the European Commission shows that Apple acquired Sonera, a startup based in California, earlier in 2026. Neither Apple nor Sonera disclosed the specific value or other terms of the transaction.
Sonera develops novel biomagnetic sensing technology. The company has said its technology can measure magnetic fields generated by the brain and body in a non-invasive manner, analyzing neural data without direct contact with the skin. Compared with traditional electrical signal detection that relies on electrode contact, this approach does not require direct skin contact, enabling more flexible wearable form factors.
In materials published in 2023, Sonera stated that its proprietary technology aims to make brain activity measurement as convenient as tracking physiological indicators such as heart rate and body temperature. The company has developed a biomagnetic chip that could be used in applications including more advanced prosthetic control, continuous monitoring of neuromuscular diseases, discovery of disease biomarkers, and sports performance tracking.
Apple has not yet announced specific product plans.
Why this event matters
The event has a measured impact on 3 industrys. The strongest current signal is positive for Electronic Components, with intensity 60/100 and 70% confidence over a medium term horizon.
Electronic Components
- Direction
- positive
- Intensity
- 60
- Confidence
- 70%
- Horizon
- Medium term
Consumer Electronics
- Direction
- positive
- Intensity
- 55
- Confidence
- 65%
- Horizon
- Medium term
Medical Equipment
- Direction
- positive
- Intensity
- 50
- Confidence
- 60%
- Horizon
- Medium term
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.